Cite
MLA Citation
Tamara J. Dunn et al.. “A phase 1, open‐label, dose‐escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma.” British journal of haematology, vol. 173, 2016, pp. 253–259. http://access.bl.uk/ark:/81055/vdc_100031857408.0x000058